Headline Sponsor Social Media Sponsor

For information on table bookings and sponsorship contact: Matt DiasT +44 (0)20 7017 4188 | M +44 (0)78 8748 4672 | matt.dias@informa.com

Scrip AwardsPharma intelligence | informa

We are delighted to announce the shortlist for the 12th Annual Scrip Awards.Over the summer, our panel of 15 respected judges has reviewed all the entries to produce a shortlist that displays the wealth of innovation, dedication and hard work that the pharmaceutical and biotech industries have demonstrated over the past year. The full range of industry activities from big pharma, biotech companies and CROs is represented: from novel deals, to new drug launches and finding technological breakthroughs in clinical trials.

The Scrip Awards provides the industry with an opportunity to acknowledge its highest achievers across all parts of the value chain, and to recognize both corporate and individual achievement. This year we have introduced a new category to celebrate the smaller CROs, as well as an award to applaud the initiatives that pharma makes in the wider world with the Community Partnership of the Year.

As in previous years, we will be announcing the winner of PPD’s Pharma Company of the Year Award on the night, just as we do for the Lifetime Achievement Award. We are thrilled that so many of you have taken the time to submit your entries. The winners will be announced at a glittering black tie ceremony at London’s Grosvenor House Hotel on 30 November.

Congratulations to all our finalists and good luck on the night!

www.scripawards.com

Scrip AwardsFinalists 2016

BEST COMPANY INAN EMERGING MARKET• Alembic Pharmaceuticals (India)• ASLAN Pharmaceuticals (Singapore)• Beximco Pharmaceuticals (Bangladesh)• Hutchison MediPharma (China)• Mundipharma Singapore (Singapore)• Torrent Pharmaceuticals (India)

COMMUNITY PARTNERSHIPOF THE YEAR AWARD• AbbVie’s Hepatitis C Global Media Education Initiative• GlaxoSmithKline’s Newborn Survival Project• Novartis’s Novartis Access social business program• Pfizer’s Corporate Social Responsibility Projects• Quintiles Research (India)’s Race for 7: We Care for Rare • The Weinberg Group’s Building STEPS

WUXI APPTEC’S BIOTECH COMPANYOF THE YEAR AWARD• Alexion Pharmaceuticals• BioNTech• Genmab• Incyte Corporation• Innate Pharma• Sosei Group (and Heptares Therapeutics)

MANAGEMENT TEAM OF THE YEAR• AstraZeneca’s Business Development Operations Leadership team• Faron Pharmaceuticals’ Management Team• Galapagos’ Management Team• Genmab’s Core Leadership Team• Horizon Discovery Group’s Management Team• Oxford BioTherapeutics’ Management Team

QUINTILES’ CLINICAL ADVANCEOF THE YEAR AWARD• Bone Therapeutics’ Phase IIa study of PREOB in osteoporosis• Kiadis Pharma’s Phase II study of ATIR101 in hematological cancers• Novo Nordisk’s LEADER cardiovascular outcomes study of liraglutide • Radius Health’s Phase III ACTIVE study of abaloparatide in osteoporosis• Summit Therapeutics’ Phase II CoDIFy study of ridinilazole in Clostridium difficile infection• Tocagen’s proof-of-concept trial of Toca 511 and Toca FC gene therapy in high-grade glioma

BEST PARTNERSHIP ALLIANCE – SPONSORED BY INC RESEARCH• AstraZeneca and Human Longevity’s genomic partnership • AstraZeneca and Moderna Therapeutics for immuno-oncology mRNA therapeutics• AstraZeneca and Sanofi’s Compound Collection Exchange • BioNTech and Sanofi’s alliance for mRNA-based immune-oncology therapies• Horizon Discovery Group and Centauri Therapeutics’ immuno-oncology joint venture Avvinity Therapeutics• Orion Pharma’s partnership with DZNE (German Center for Neurodegenerative Diseases)

EXECUTIVE OF THE YEAR – SPONSORED BY LACHMAN CONSULTANTS• Eliot Forster, CEO of Immunocore• Mireille Gillings, founder and executive chair of HUYA Bioscience International• Brent Saunders, president and CEO of Allergan• Raman Singh, president of Mundipharma Asia Pacific, Latin America, Middle East and Africa• Onno van de Stolpe, founder and CEO of Galapagos• Jan van de Winkel, president and CEO of Genmab

HUYA BIOSCIENCE INTERNATIONAL’S BEST NEW DRUG AWARD• Johnson & Johnson/Genmab’s Darzalex (daratumumab) • Sanofi Pasteur’s Dengvaxia (tetravalent dengue vaccine)• Novartis’s Entresto (sacubitril/valsartan)• Alexion Pharmaceuticals’ Kanuma (sebelipase alfa)• Alexion Pharmaceuticals’ Strensiq (asfotase alfa)• Allergan’s Viberzi (eluxadoline)

LICENSING DEAL OF THE YEAR• AstraZeneca’s acquisition of Takeda's • Galapagos and Gilead Sciences for core respiratory portfolio filgotinib in inflammatory diseases• Heptares Therapeutics and Allergan for • HUYA Bioscience International and muscarinic receptor agonists in CNS diseases Eisai for HBI-8000 in oncology• WuXi AppTec and Lilly for a novel cardiovascular candidate in China • Ipsen and Exelixis for cabozantinib in oncology

BEST TECHNOLOGICALDEVELOPMENT IN CLINICAL TRIALS– SPONSOR-FOCUSED• ClinCapture’s cloud-based EDC system• Cytel’s EnForeSys • DrugDev Golden Number• ICON Firecrest Digital Suite• Medidata Solutions’ Medidata Payments• Quintiles’ Predictive and Advanced Analytics Platform

BEST TECHNOLOGICAL DEVELOPMENT IN CLINICAL TRIALS – PATIENT-FOCUSED• AiCure’s artificial intelligence DOT smartphone app• AMRA’s Profiler Research rapid MRI scan service• CRF Health’s TrialConsent electronic informed consent technology• ERT’s wireless Electrocardiogram/ electronic Clinical Outcome Assessment solution• Hip Impact Protection’s Fall-Safe Assist system

BEST CONTRACT RESEARCH ORGANIZATION– FULL-SERVICE PROVIDERS• ICON• INC Research• Pharm-Olam International • PPD• Quintiles• Worldwide Clinical Trials

BEST CONTRACT RESEARCHORGANIZATION – NICHE PROVIDERS• Altasciences Clinical Research• BioAgilytix• Imanova• PHASTAR• Tioga Research

FINANCING DEAL OF THE YEAR• Atlantic Healthcare’s $24m financing• Cassiopea’s initial public offering• Immunocore’s $320m series A financing • Mereo BioPharma’s £76.5m private placement• MISSION Therapeutics’ £60m series C financing